Tina Albertson – Biography
Last update: March 23, 2026Executive profile
Tina was Chief Medical Officer and Head of Development at Lyell Immunopharma, and Vice President of Global Drug Development at Juno Therapeutics. Tina Albertson joined Caribou Biosciences in 2024.
Tina Albertson is currentlyChief Medical Officer at Caribou Biosciences - View - Caribou Biosciences org chart
Create your alert
to follow the career of Tina Albertson.
Education
Tina Albertson has a Doctor of Medicine from Stanford University and a PhD in Cancer Biology from University of Washington.
They have also studied at Stanford University :
Find more alumni from Stanford University
They have also studied at University of Washington :
Find more alumni from University of Washington
More about Tina Albertson
Selected links
Do you need to know more about Tina Albertson? More results.
Participate
Social media
- Tina Albertson on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Tina Albertson
The colleagues of Tina Albertson
Company Colleagues
- At Caribou Biosciences, Tina Albertson has 24 colleagues including Rachel Haurwitz (CEO & Director), Natalie Sacks (Director)…
Industry Colleagues
- In the Biotechnology industry, Tina Albertson has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Tina Albertson.
Get in Touch
Here are a few tips for establishing great contacts.
